Why the study?
Does AT1A receptor disruption or antagonism prevent atherosclerosis and endothelial dysfunction in ApoE-/- mice on a high-cholesterol diet?
Population
Wild-type (C57BL/6J), ApoE-/-, AT1-/-, and ApoE-/--AT1-/- mice fed a high-cholesterol diet
Comparison
Genetic disruption of the AT1A receptor or oral… vs ApoE-/- mice or oral treatment with hydralazine
Design
Preclinical
Follow-up
7 weeks
Authors
Loading...
Should not change clinical practice; leaves open whether AT1A antagonism prevents human atherosclerosis.
Does AT1A receptor disruption or antagonism prevent atherosclerosis and endothelial dysfunction in ApoE-/- mice on a high-cholesterol diet?
AT1 receptor activation plays a fundamental role in atherogenesis, independent of blood pressure and cholesterol levels, highlighting its potential as a therapeutic target in atherosclerosis.
Waßmann et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: